Kernal Biologics, Inc. — Form D
Kernal Biologics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-08-15. The offering totals $1.0M, of which $500K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2018-08-15
- Form: D
- Accession: 0001684728-18-000003
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $500K
- Remaining: $500K
- Investors: 1
- Date of first sale: 2018-08-02
- Revenue range: Decline to Disclose
- SEC file number: 021-319260
Issuer
- Name: Kernal Biologics, Inc.
- CIK: 0001684728
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 700 MAIN STREET, CAMBRIDGE, MA, 02139
- Phone: 781-999-4008
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Oguzhan Yilmaz | Director | Cambridge, MA |
| Yusuf Erkul | Director | Cambridge, MA |
| Yusuf Erkul | Executive Officer | Cambridge, MA |
| Burak Yilmaz | Director | Cambridge, MA |
| Burak Yilmaz | Executive Officer | Cambridge, MA |
| Catherine Moroski | Director | Cambridge, MA |
| Catherine Moroski | Executive Officer | Cambridge, MA |
| Oguzhan Yilmas | Director | Cambridge, MA |
Other filings by this issuer (2)
More